| ID Source | ID |
|---|---|
| PubMed CID | 11788788 |
| CHEBI ID | 182516 |
| CHEBI ID | 24464 |
| SCHEMBL ID | 4266355 |
| MeSH ID | M0051361 |
| Synonym |
|---|
| (2s,3r,4r,5r)-3,4,5,6-tetrahydroxyoxane-2-carboxylic acid |
| d-guluronic acid |
| CHEBI:182516 |
| guluronic acid |
| SCHEMBL4266355 |
| guluronate |
| GULA , |
| d-guluronate |
| gulopyranuronic acid |
| d-gulopyranuronate |
| d-gulopyranuronic acid |
| gulopyranuronate |
| d-gula |
| C21047 |
| galakturonsaure |
| g2013 compound |
| chebi:24464 |
| Class | Description |
|---|---|
| carbohydrate acid derivative | A carbohydrate derivative that is formally obtained from a carbohydrate acid. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (0.63) | 18.7374 |
| 1990's | 21 (13.21) | 18.2507 |
| 2000's | 39 (24.53) | 29.6817 |
| 2010's | 73 (45.91) | 24.3611 |
| 2020's | 25 (15.72) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 7 (4.14%) | 5.53% |
| Reviews | 2 (1.18%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 160 (94.67%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Article | Year |
|---|---|
| The Evaluation of Safety Property and Apoptotic Efficacy of α-L-Guluronic Acid (G2013), as a Novel NSAID, Under Recent advances in inflammation & allergy drug discovery, Volume: 15, Issue: 1 | 2022 |
| The safety and efficacy of Guluronic acid (G2013) in ankylosing spondylitis: A randomized controlled parallel clinical trial. Pharmacological reports : PR, Volume: 71, Issue: 3 | 2019 |
| [information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | |
| Article | Year |
|---|---|
| MSC encapsulation in alginate microcapsules prolongs survival after intra-articular injection, a longitudinal in vivo cell and bead integrity tracking study. Cell biology and toxicology, Volume: 36, Issue: 6 | 2020 |
| Schiff base - Chitosan grafted L-monoguluronic acid as a novel solid-phase adsorbent for removal of congo red. International journal of biological macromolecules, Volume: 82 | 2016 |
| New therapeutic approach by G2013 in experimental model of multiple sclerosis. Acta neurologica Belgica, Volume: 115, Issue: 3 | 2015 |
| Evaluation of sodium alginate as drug release modifier in matrix tablets. International journal of pharmaceutics, Feb-17, Volume: 309, Issue: 1-2 | 2006 |
| [information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | |